Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068925 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
A Phase 1 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01068925 is a Phase 1 study that has completed, run by ViiV Healthcare. The registered enrollment target is 18 participants.
The verdict
NCT01068925, a Phase 1 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a drug interaction between GSK1349572 and the HIV protease inhibitors Tipranavir/Ritonavir (TPV/RTV).
Interventions
- DRUG GSK1349572
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-02-15 |
| Est. Completion | 2010-04-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068925
The ClinicalTrials.gov registry entry for NCT01068925 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK1349572 is the first listed.
NCT01068925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068925 about?
NCT01068925 is a clinical study titled "Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers". The purpose of this study is to determine whether there is a drug interaction between GSK1349572 and the HIV protease inhibitors Tipranavir/Ritonavir (TPV/RTV).
What is the current status of trial NCT01068925?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2010-02-15. Estimated completion is 2010-04-05.
What interventions are being tested in trial NCT01068925?
The interventions under investigation include: GSK1349572 (DRUG).
Who is sponsoring clinical trial NCT01068925?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.